Release Date: 01/04/19 09:28 Summary: Notice of Annual General Meeting/Proxy Form Price Sensitive: No Download Document 903.06KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%